November 25, 2019

US leads Global Axial Spondyloarthritis Market with 74.7% of Global Sales Revenue

Axial Spondyloarthritis (AxSpA) effects sacroiliac joints and axial skeleton and its primary symptoms include inflammatory back pain. It consists of ankylosing spondylitis and non-radiographic axial Spondyloarthritis. Its causes various sudo-inflammatory and chronic disorders of spine and sacroiliac joints which are collectively referred as axial skeleton. Average diagnosis age is between 16 to 45 years and is known to get diagnosed late by seven to nine years. Anti-tumor necrosis factor therapies form a major segment of global Axial Spondyloarthritis market. An intelligence report titled, “Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028” is the source of all the stated insights. This report is the latest addition to Market Research Hub’s ever growing repository

Request Sample Report@

Huge scope of drug development

Global market is witnessing momentum in treatment sector with novel treatment mechanisms and drugs. Novartis launched Cosentyx which is first class interleukin inhibitor and is known to be the first approved anti-TNF treatment for AS. Biosimilar for the commercial anti-TNF biologics have emerged in market such as Remicade biosimilar which surfaced in Europe. Arrival of new drugs and treatment including IL-17 treatment and Janase Kinase inhibitors have amped up the competitive landscape in global Axial Spondyloarthritis market. Drug development in this segment has huge scope of development owing to insufficient treatment, especially for nr-axSpA patients. Launch of major therapies including Eli Lillys taltz and Pfizers tofacitinib drives the global Axial Spondyloarthritis market growth.

The drug market was evaluated to grow at 1.5% CAGR in the forecast period 2018-2028 and it will amount to $3.6Bn by the end of this period. US leads the global market with $2.3Bn revenue from drugs sale which accounts to be 74.7% of the global sale. On the other hand, Japan is expected to witness decrease in sales and come down to generating only 1.5% of the global sales in coming decade.

The global market growth is inhibited by different factors that include patent expiry and genericization of tofacitinib.

Browse Complete Research Report with TOC@

Global Axial Spondyloarthritis market: Report Synopsis

Quantitative and qualitative assessment exhort intelligence and overarching report on the Global Axial Spondyloarthritis market. Further, the report thoroughly delineates various aspects of the market that will potentially have considerable influence on the development of the Global Axial Spondyloarthritis market. As such, those aspects incorporate drivers, trends, restraints, and opportunities. Furthermore, the report elucidates segregation of the market that provides an exhaustive analysis on Axial Spondyloarthritis.

An insightful and deep-dive assessment of the competitive assessment of the Global Axial Spondyloarthritis market pins hope on Porters’ Five Force Analysis. Accordingly, the Porters’ Five Force Analysis offers a pressing analysis on the potential strategies of the preeminent players in the Global Axial Spondyloarthritis market. In addition, the business strategies counts on company overview, product portfolio, SWOT analysis, key differentiation and recent development.

Global Axial Spondyloarthritis market: Research Methodology

Primary sources and secondary sources propel intelligence report on Global Axial Spondyloarthritis market that provide deep dive analysis on the market. As such, the report provides reliable and unbiased projections, and assessments which have palpable impact on the market size and historical data. Besides, the report also counts on primary sources which hinges upon in-depth and intelligent analysis from well-grounded and reliable experts, telephonic interview, and a thorough assessment from surveys and seasoned analyst.

Make An Enquiry About This Report @

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceutical market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)


Read Industry News at: